TipRanks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
VIR
Vir Biotechnology
RESEARCH TOOLSreports
Want to see VIR full AI Analyst Report?

Vir Biotechnology (VIR) Balance Sheet

1,561 Followers

Vir Biotechnology Balance Sheet

Vir Biotechnology's total assets for Q2 2026 were $1.21B, an increase of 18.45% from the previous quarter. VIR total liabilities were $232.31M for the fiscal quarter, a 9.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.00B$ 1.40B$ 1.92B$ 2.80B$ 1.95B
Total Liabilities
$ 237.55M$ 248.43M$ 328.82M$ 724.13M$ 522.42M
Total Equity Gross Minority
$ 765.28M$ 1.15B$ 1.59B$ 2.08B$ 1.43B
Other Metrics
Currency in USD

Vir Biotechnology Debt to Assets